In ER +/HER2+ breast cancer, this heterogeneity is particularly evident in the differential expression patterns of ER and HER2 across tumor regions, with some cell populations showing high ER/low HER2 expression while others exhibit different profile [49]. This evidence concerns the gene ERBB2 and breast carcinoma.